The high incidence of rectal cancer in both sexes makes it one of the most common tumors,
with significant morbidity and mortality rates. To define the best treatment option and …

Rectal cancer (RC) is the third most commonly diagnosed cancer and has a high risk of
mortality, although overall survival rates have improved. Preoperative assessments and …

While cross-sectional imaging has seen continuous progress and plays an undiscussed
pivotal role in the diagnostic management and treatment planning of patients with rectal …

Rectal cancer (RC) is one of the most common tumours worldwide in both males and
females, with significant morbidity and mortality rates, and it accounts for approximately one …

Simple Summary Worldwide gastrointestinal (GI) malignancies account for about 25% of the
global cancer incidence. For some malignancies, screening programs, such as routine colon …

Diagnosis and treatment of locally advanced rectal cancer is mainly based on multimodal
approach for staging, planning and treatment. The modern radiological and imaging …

Introduction As computational capabilities have advanced, radiologists and their
collaborators have looked for novel ways to analyze diagnostic images. This has resulted in …

Colorectal cancer is the third most common type of cancer, with high morbidity and mortality
rates. In particular, locally advanced rectal cancer (LARC) is difficult to treat and has a high …

The main therapeutic options for colorectal cancer are surgical resection and adjuvant
chemotherapy in non-metastatic disease. However, the evaluation of the overall adjuvant …

Neoadjuvant chemo-radiotherapy (CRT) followed by total mesorectal excision (TME)
represents the standard treatment for patients with locally advanced (≥ T3 or N+) rectal …